Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Bile Duct Neoplasms × Stents × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Klatskin Tumor 1 Bile Duct Neoplasms 1

Interventions

Gemcitabine 18 Fluorouracil 14 Cisplatin 10 Capecitabine 9 Leucovorin 8 durvalumab 6 Oxaliplatin 6 Erlotinib Hydrochloride 4 Radiotherapy 3 trifluridine tipiracil drug combination 2 trametinib 2 regorafenib 2 pembrolizumab 2 ceralasertib 2 Sorafenib 2 Radiosurgery 2 Irinotecan 2 Filgrastim 2 AZD 6244 2 zimberelimab 1 tremelimumab 1 titanium silicide 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 seribantumab 1 quemliclustat 1 olaparib 1 ixabepilone 1 galactomannan 1 exatecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06274879 2025-01-09

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡